CAS RN: 131167-89-0

isoleucyl-lysyl-valyl-alanyl-valine

Product Availability

Choose a grade to view its available package options.

6 package records6 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250220 100mg In stock Shanghai Inquiry
Batchno.20260611 10mg In stock Shanghai Inquiry
Batchno.20250505 250mg In stock Shanghai Inquiry
Batchno.20250303 25mg In stock Shanghai Inquiry
Batchno.20260509 50mg In stock Shanghai Inquiry
Batchno.20251231 5mg In stock Shanghai Inquiry
  • Product code: starshine_CAS131167-89-0
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

131167-89-0 / (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-3-methylbutanoic acid

Standard CAS: 131167-89-0 Multi CAS: No

Basic Information

CAS
131167-89-0
Multi CAS
No
Molecular Formula
C25H48N6O6
Molecular Weight
528.700000
Exact Mass
528.363533
SMILES
CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O)N
InChI
InChI=1S/C25H48N6O6/c1-8-15(6)18(27)23(34)29-17(11-9-10-12-26)22(33)30-19(13(2)3)24(35)28-16(7)21(32)31-20(14(4)5)25(36)37/h13-20H,8-12,26-27H2,1-7H3,(H,28,35)(H,29,34)(H,30,33)(H,31,32)(H,36,37)/t15-,16-,17-,18-,19-,20-/m0/s1
InChIKey
XQQUSYWGKLRJRA-RABCQHRBSA-N

Computed Properties

Structural Parameters

Heavy atom count
37
Fraction Csp3
0.8
Rotatable bonds
17
H-bond acceptors
7
H-bond donors
7
Molar refractivity
141.04
TPSA
205.74

LogP / Solubility

WLOGP
-0.16
MLOGP
-0.1
XLogP3
-2.7
Consensus LogP
-0.99
Log S (ESOL)
-1.9
Class (ESOL)
Soluble
Log S (Ali)
-3.78
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-5.01
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-6.06

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
7

Get In Touch

Contact Us